Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Eliopoulos

Showing results (81-90 of 125) with videos related to

Pageof 13
Sort By:
Antimicrobial Agents and Chemotherapy|April 1, 1995
Comparative in vitro activities of L-695,256, a novel carbapenem, against gram-positive bacteriaG Malanoski, L Collins, C T Eliopoulos, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1989
Effect of blood product medium supplements on the activity of cefotaxime and other cephalosporins against Enterococcus faecalisG M Eliopoulos, E Reiszner, S Willey, et al.
Antimicrobial Agents and Chemotherapy|June 13, 1998
Susceptibilities of Legionella spp. to newer antimicrobials in vitroT Schülin, C B Wennersten, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy|June 11, 1991
Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess modelL B Rice, J D Yao, K Klimm, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1984
Ribosomal resistance of clinical enterococcal to streptomycin isolatesG M Eliopoulos, B F Farber, B E Murray, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1983
Resistance to penicillin-streptomycin synergy among clinical isolates of viridans streptococciB F Farber, G M Eliopoulos, J I Ward, et al.
Antimicrobial Agents and Chemotherapy|January 11, 1992
Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimensT L Hodges, S Zighelboim-Daum, G M Eliopoulos, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830)G M Eliopoulos, K Klimm, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1993
In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteriaG M Eliopoulos, K Klimm, C T Eliopoulos, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1990
Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agentG M Eliopoulos, K Klimm, L B Rice, et al.
Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|April 1, 1995
Comparative in vitro activities of L-695,256, a novel carbapenem, against gram-positive bacteriaG Malanoski, L Collins, C T Eliopoulos, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1989
Effect of blood product medium supplements on the activity of cefotaxime and other cephalosporins against Enterococcus faecalisG M Eliopoulos, E Reiszner, S Willey, et al.
Antimicrobial Agents and Chemotherapy|June 13, 1998
Susceptibilities of Legionella spp. to newer antimicrobials in vitroT Schülin, C B Wennersten, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy|June 11, 1991
Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess modelL B Rice, J D Yao, K Klimm, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1984
Ribosomal resistance of clinical enterococcal to streptomycin isolatesG M Eliopoulos, B F Farber, B E Murray, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1983
Resistance to penicillin-streptomycin synergy among clinical isolates of viridans streptococciB F Farber, G M Eliopoulos, J I Ward, et al.
Antimicrobial Agents and Chemotherapy|January 11, 1992
Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimensT L Hodges, S Zighelboim-Daum, G M Eliopoulos, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830)G M Eliopoulos, K Klimm, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1993
In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteriaG M Eliopoulos, K Klimm, C T Eliopoulos, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1990
Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agentG M Eliopoulos, K Klimm, L B Rice, et al.
Pageof 13